Pricing Log in Create free account

aTyr Pharma, Inc. (ATYR) vs Psyence Biomedical Ltd. (PBM)

aTyr Pharma, Inc. and Psyence Biomedical Ltd. are both Biotechnology companies. aTyr Pharma, Inc. and Psyence Biomedical Ltd. are of similar size ($18.0M and $16.5M). aTyr Pharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Psyence Biomedical Ltd. trades at 0.2×. Across the 10 metrics below, Psyence Biomedical Ltd. leads on 6 and aTyr Pharma, Inc. on 4.

Valuation

Metric ATYR PBM Biotechnology median
P/E n/m 0.19 8.50
P/S 1.49 n/m 9.71
P/B 0.34 0.08 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.59 1.82 0.64
EV/Sales (3.37) n/m 9.21
Earnings yield (364.71%) 534.77% (33.15%)
Free cash flow yield (328.74%) (807.70%) (25.50%)

Profitability

Metric ATYR PBM Biotechnology median
Gross margin 1.72% — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (98.67%) (23.52%) (56.36%)
Return on assets (70.97%) (6.74%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATYR PBM Biotechnology median
Revenue growth (TTM) 6.78% — 6.02%
EPS growth (last fiscal year) 6.98% (138.35%) 30.26%
Revenue growth, 5-year CAGR (14.75%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATYR PBM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.12 8.09 4.72
Net debt to EBITDA 1.01 1.20 0.96

Dividend

Metric ATYR PBM Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ATYR PBM Biotechnology median
Market cap 18.03m 16.47m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack